ARCHIVES

BMI May Be Prognostic Tool For Types Of Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action

January 9, 2009

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

Community-Based Program Final Planning Review In August, October

August 6, 1976

Baltimore Reports On New Method To Aid Leukemia Therapy Design

May 20, 1977